Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro.

The renal cell carcinoma (RCC) is extremely resistant to chemotherapy and radiotherapy. The prognosis of patients with metastatic RCC still remains poor, the median survival is less than 12 months. Therefore, new therapeutic options are desirable.